share_log

Institutional Investors in APT Medical Inc. (SHSE:688617) See CN¥2.3b Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.

Institutional Investors in APT Medical Inc. (SHSE:688617) See CN¥2.3b Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.

APT Medical Inc.(上海证券交易所代码:688617)的机构投资者上周的市值下降了23亿元人民币,尽管长期收益使他们受益。
Simply Wall St ·  05/27 22:42

Key Insights

关键见解

  • Given the large stake in the stock by institutions, APT Medical's stock price might be vulnerable to their trading decisions
  • 51% of the business is held by the top 8 shareholders
  • Insiders own 28% of APT Medical
  • 鉴于机构持有该股的大量股份,APT Medical的股价可能容易受到其交易决策的影响
  • 51% 的业务由前 8 名股东持有
  • 业内人士拥有APT Medical28%的股份

If you want to know who really controls APT Medical Inc. (SHSE:688617), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are institutions with 37% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

如果你想知道谁真正控制了APT Medical Inc.(上海证券交易所代码:688617),那么你必须看看其股票登记处的构成。而持有最大份额的集团是拥有37%所有权的机构。换句话说,该集团将从对公司的投资中获得最多(或损失最大)。

Institutional investors was the group most impacted after the company's market cap fell to CN¥34b last week. However, the 34% one-year return to shareholders might have softened the blow. We would assume however, that they would be on the lookout for weakness in the future.

上周该公司的市值跌至340亿元人民币后,机构投资者是受影响最大的群体。但是,34%的股东一年回报率可能减轻了打击。但是,我们假设他们将来会注意弱点。

Let's delve deeper into each type of owner of APT Medical, beginning with the chart below.

让我们从下图开始,深入研究APT Medical的每种类型的所有者。

ownership-breakdown
SHSE:688617 Ownership Breakdown May 28th 2024
SHSE: 688617 所有权明细 2024 年 5 月 28 日

What Does The Institutional Ownership Tell Us About APT Medical?

关于APT Medical,机构所有权告诉我们什么?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

机构投资者通常将自己的回报与常见指数的回报进行比较。因此,他们通常会考虑收购相关基准指数中包含的大型公司。

As you can see, institutional investors have a fair amount of stake in APT Medical. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at APT Medical's earnings history below. Of course, the future is what really matters.

如你所见,机构投资者在APT Medical中拥有相当数量的股份。这意味着在这些机构工作的分析师已经看过这只股票,他们很喜欢。但是就像其他人一样,他们可能错了。如果多家机构同时改变对股票的看法,你可能会看到股价快速下跌。因此,值得在下面查看APT Medical的收益记录。当然,未来才是真正重要的。

earnings-and-revenue-growth
SHSE:688617 Earnings and Revenue Growth May 28th 2024
SHSE: 688617 收益和收入增长 2024 年 5 月 28 日

We note that hedge funds don't have a meaningful investment in APT Medical. Looking at our data, we can see that the largest shareholder is the CEO Zhenghui Cheng with 25% of shares outstanding. For context, the second largest shareholder holds about 5.5% of the shares outstanding, followed by an ownership of 4.6% by the third-largest shareholder.

我们注意到,对冲基金没有对APT Medical进行有意义的投资。从我们的数据来看,我们可以看到最大股东是首席执行官程正辉,其已发行股份的25%。就背景而言,第二大股东持有约5.5%的已发行股份,其次是第三大股东持有4.6%的所有权。

We also observed that the top 8 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent.

我们还观察到,前8名股东占股票登记册的一半以上,少数规模较小的股东可以在一定程度上平衡大股东的利益。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

虽然研究公司的机构所有权可以为您的研究增加价值,但研究分析师的建议以更深入地了解股票的预期表现也是一种好做法。有相当数量的分析师在报道该股,因此了解他们对未来的总体看法可能很有用。

Insider Ownership Of APT Medical

APT Medical 的内部所有权

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

不同国家对内部人士的定义可能略有不同,但董事会成员始终算在内。管理层最终对董事会负责。但是,经理成为执行委员会成员的情况并不少见,尤其是当他们是创始人或首席执行官时。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

当内部所有权表明领导层像公司的真正所有者一样思考时,内部所有权是积极的。但是,高度的内部所有权也可以赋予公司内部的一小部分人巨大的权力。在某些情况下,这可能是负面的。

Our most recent data indicates that insiders own a reasonable proportion of APT Medical Inc.. Insiders own CN¥9.7b worth of shares in the CN¥34b company. That's quite meaningful. Most would say this shows a good degree of alignment with shareholders, especially in a company of this size. You can click here to see if those insiders have been buying or selling.

我们最新的数据表明,内部人士拥有APT Medical Inc.合理比例的股份。内部人士拥有这家340亿元人民币公司价值97亿元人民币的股份。这很有意义。大多数人会说,这表明了与股东的良好一致性,尤其是在如此规模的公司中。你可以点击这里查看这些内部人士是否在买入或卖出。

General Public Ownership

一般公有制

The general public-- including retail investors -- own 27% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

包括散户投资者在内的公众拥有该公司27%的股份,因此不容忽视。尽管这种所有权规模可能不足以影响对他们有利的政策决定,但它们仍然可以对公司政策产生集体影响。

Private Company Ownership

私人公司所有权

Our data indicates that Private Companies hold 8.0%, of the company's shares. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

我们的数据显示,私人公司持有公司8.0%的股份。私营公司可能是关联方。有时,内部人士通过控股私营公司而对上市公司拥有权益,而不是以个人身份拥有权益。尽管很难得出任何宽泛的结论,但值得注意的是,这是一个需要进一步研究的领域。

Next Steps:

后续步骤:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Be aware that APT Medical is showing 1 warning sign in our investment analysis , you should know about...

我觉得看看究竟谁拥有一家公司非常有趣。但是,要真正获得见解,我们还需要考虑其他信息。请注意,APT Medical在我们的投资分析中显示了1个警告信号,你应该知道...

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

如果你想了解分析师对未来增长的预测,千万不要错过这份关于分析师预测的免费报告。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的数字是使用过去十二个月的数据计算得出的,这些数据是指截至财务报表日期当月最后一天的12个月期间。这可能与全年年度报告数据不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发